These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7439055)

  • 1. [Global and regional left ventricular function in coronary heart disease after beta-blockade and furosemide (author's transl)].
    Nechwatal W; Sigel H; Bitter F; Geffers H; Kress P; Adam WE; Stauch M
    Dtsch Med Wochenschr; 1980 Nov; 105(48):1687-93. PubMed ID: 7439055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the beta blocker penbutolol on human hemodynamic parameters and the heart conduction system].
    Biamino G; Schüren KP; von Leitner E
    Verh Dtsch Ges Inn Med; 1978; (84):697-700. PubMed ID: 742102
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative beta adrenoreceptor blocking effect of propranolol and penbutalol. Preliminary observations.
    Khanna PK; Balasubramanian V; Chatterji JC; Hoon RS
    J Assoc Physicians India; 1978 Mar; 26(3):143-6. PubMed ID: 32165
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extent of beta-blocking action of S- and R-penbutolol during exercise testing (author's transl)].
    Kober G; Schulz W; Hermann HJ; Kaltenbach M
    Z Kardiol; 1982 Apr; 71(4):289-94. PubMed ID: 6283753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with oxyphedrine. Action on the heart and coronary therapy (author's transl)].
    Castillo Bernal A; Sáez de Santa María IE
    Folia Clin Int (Barc); 1974; 24(7):573-8. PubMed ID: 4408919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of propranolol on left ventricular function at rest and during exercise in patients with ischemic heart disease (author's transl)].
    Jebavý P; Ressl J; Jandová R
    Cas Lek Cesk; 1974 Feb; 113(7):199-205. PubMed ID: 4434438
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 8. [The hypertensive heart. VII. Effect of atenolol on the function, coronary haemodynamics and oxygen uptake of the left ventricle (author's transl)].
    Strauer BE
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1785-9. PubMed ID: 710288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical electrophysiological properties of penbutolol: a non-selective beta-blocking agent.
    von Leitner ER; Biamino G
    Eur J Cardiol; 1980; 12(2):121-8. PubMed ID: 7439238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J; Härtfelder G; Lindner E; Schölkens B
    Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular function and beta-blockade in chronic ischaemic heart failure. Double-blind, cross-over study of propranolol and penbutolol using non-invasive techniques.
    Vedin A; Wikstrand J; Wilhelmsson C; Wallentin I
    Br Heart J; 1980 Jul; 44(1):101-7. PubMed ID: 7000099
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the cardiovascular effects of the beta-blockader atenolol].
    Lucatti A; Delfino R; Musso G; Gazzarata M; Oldoino E; Spirito P
    Arch Sci Med (Torino); 1983; 140(2):177-82. PubMed ID: 6882193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left ventricular dynamics with exercise after revascularization in advanced coronary heart disease (author's transl)].
    Sigwart U; Trieb G; Leitz KH; Dragojevic D; Mertens HM; Borst HG; Gleichmann U
    Thoraxchir Vask Chir; 1978 Jun; 26(3):214-7. PubMed ID: 675660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The excretion of renal enzymes during rest and exercise: a double-blind comparison between placebo and penbutolol.
    Verho M; Färber G; Heinen B; Grötsch H
    Int J Clin Pharmacol Res; 1987; 7(1):27-32. PubMed ID: 2884191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of betapressin on respiratory measurements and stress ECG in patients with coronary disease].
    Felder K
    Ther Ggw; 1981 Jun; 120(6):559-70. PubMed ID: 7281044
    [No Abstract]   [Full Text] [Related]  

  • 16. Left ventricular function and regional myocardial blood flow after atenolol in normals and patients with coronary artery disease.
    Lichtlen P; Amende I; Simon R; Engel HJ; Hundeshagen H
    Postgrad Med J; 1977; 53 Suppl 3():85-9. PubMed ID: 928273
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ergometric dose-effect study of bunitrolol (Stresson) in patients with coronary heart disease (author's transl)].
    Böhm H; Höhm B; Ludwig B; Madl W; Werner F
    Wien Med Wochenschr; 1981 Sep; 131(18):457-61. PubMed ID: 6117988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of diastolic function and exercise capacity in ischemic left ventricular dysfunction. Role of beta-agonists and beta-antagonists.
    Pouleur H; Hanet C; Rousseau MF; van Eyll C
    Circulation; 1990 Aug; 82(2 Suppl):I89-96. PubMed ID: 1973644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behaviour of left ventricular systolic time intervals after isometric exercise in patients with ischemic heart disease (author's transl)].
    Rosselli P; Martini U; Iannetti M; Pastorini C; Masperone MA; Caponnetto S
    G Ital Cardiol; 1975; 5(3):364-71. PubMed ID: 1149963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.